Stay current on changes and developments in corporate law with a wide variety of resources and tools.
By Michael Greene
April 8 — During oral argument in a case about Wal-Mart's high-capacity gun sales, a panel of Third Circuit judges April 8 peppered both sides with questions about the scope of the SEC's “ordinary business” proxy exclusion rule and seemed bothered about where to draw the dividing line.
The panel raised questions about the SEC's interpretation of Rule 14a-8(i)(7) and whether they should defer to the commission; whether the size and type of business affects the interpretation of the exclusion rule; what effect a D.C. Circuit opinion from 1970—Medical Committee for Human Rights v. SEC—may have on this case; and whether the shareholder proposal at issue is impermissibly vague.
Because Wal-Mart Stores Inc. has to print its proxy statement by April 16, the panel said they would try to issue their opinion by April 15.
Wal-Mart is appealing a district court ruling that the megastore couldn't omit a shareholder proposal that sought to provide more oversight and reporting regarding the guns sold at the chain's stores under the SEC's “ordinary business” proxy exclusion rule. The district court concluded that the Securities and Exchange Commission was incorrect in providing Wal-Mart with no-action relief because Trinity Wall Street's proposal related to ordinary business operations.
During the April 8 oral arguments in Philadelphia, U.S. Court of Appeals for the Third Circuit Court Judge Thomas L. Ambro asked attorneys from both sides where they believed the line for “ordinary business” should be drawn, adding that he wasn't sure where the SEC staff draws this line, citing two decisions where no-action relief had been denied—in cases involving Denny's Corp. and Kroger Co.
Theodore J. Boutrous Jr., a partner at Gibson, Dunn & Crutcher who represented Bentonville, Ark.-based Wal-Mart, told the panel that his client has a very rigorous process for determining what products it sells. He argued that there is a distinction between proposals that affect what retailers and manufacturers sell, adding that a policy that dictates what products a retailer should sell is the essence of ordinary business.
Boutrous additionally warned the panel that endorsing this type of proposal will create an outpouring of similar proposals.
Joel E. Friedlander, a partner at Friedlander & Gorris P.A. who represented Trinity, told the panel that according to 1998 SEC staff guidance and Medical Committee for Human Rights v. SEC, the proposal is not excludable because it only asks the board to develop a policy in considering what products it sells. He added that exercising oversight is something that shareholders should expect a board to do.
The case “goes to the broader question of striking a balance between shareholder suffrage and the prerogative of management,” Boutrous told the appeals panel, which also included Judges Thomas I. Vanaskie and Patty Shwartz. A ruling for Trinity would require the retailer to scrutinize hundreds of thousands of potentially controversial products, he said.
However, Friedlander argued that the church's proposal is reasonable considering the specific risks of selling guns. “We're not asking the board to survey each item. Wal-Mart has methods of filtering out which products generate controversy. That leads to the evolution of policy,” he said.
Richard Samp, chief counsel at the Washington Legal Foundation, one of the parties that filed an amicus brief in support of Wal-Mart, told Bloomberg BNA that one of the biggest problems the Third Circuit will face in reaching a decision is the relative dearth of precedent on this issue. He added that most of the citations in the parties' briefs came from no-action letters and that the few court decisions that exist come mostly from federal district courts.
According to Samp, if the Third Circuit was to base its decision solely on no-action letters, Wal-Mart will win its appeal.
Business groups have strongly criticized the district court's ruling, and experts have given diverse predictions on how this case could impact the ongoing proxy season and other similar proposals. Conversely, several groups have filed amicus briefs in support of Trinity's position.
In its appeal, Wal-Mart claimed that “[a]bsent reversal, the District Court’s erroneous ruling will leave the Rule 14a-8(i)(7) ordinary business exclusion in tatters”.
Jeffrey Golan, of Philadelphia-based Barrack Rodos & Bacine who represented Robert F. Kennedy Center for Justice and Human Rights, one of the amicus filers, in a statement e-mailed to BBNA said that the group “wholeheartedly endorses Trinity Wall Street’s position because upholding the District Court’s decision is necessary to protect and facilitate the use of the Sustainable Investing investment philosophy as a best practice in the financial evaluation of a company and the role of shareholders.”
However, Samp believes that what Trinity is asking for is unprecedented and that it is not realistic for shareholders to play a role in determining what products a retailer sells.
Samp told BBNA that there are two bases for the Third Circuit to overturn the lower courts decision: the ordinary business exclusion rule and vagueness—and that both are interrelated. He explained that the proposal can't specifically dictate what products the companies sells, but by not doing so, it becomes vague.
To contact the reporter on this story: Michael Greene in Washington at email@example.com
To contact the editor responsible for this story: Ryan Tuck at firstname.lastname@example.org
Wal-Mart's brief is available at http://www.bloomberglaw.com/public/document/Trinity_Wall_Street_v_WalMart_Stores_Inc_Docket_No_1404764_3d_Cir/8.
Trinity Wall Street's answering brief is available at http://www.bloomberglaw.com/public/document/Trinity_Wall_Street_v_WalMart_Stores_Inc_Docket_No_1404764_3d_Cir/7.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)